Advertisement

Journal of Bioenergetics and Biomembranes

, Volume 41, Issue 2, pp 95–98 | Cite as

Mitochondrial matters of the heart: a plethora of regulatory modes to maintain function for a long lifetime

  • Peter L. Pedersen
Article

Abstract

The human/animal heart, comprised of cells called “myocytes” is an incredible organ that to remain beating must be fueled constantly via the hydrolysis of adenosine tri-phosphate (ATP). Deriving most of its ATP from mitochondrial oxidative phosphorylation (ox phos), and a smaller amount from “glycolysis”, i.e., glucose conversion to pyruvate or lactate, the heart helps in the delivery of oxygen (via hemoglobin) to every organ/tissue in our body. Then, the empty (deoxy) hemoglobin returns to load more oxygen and the journey to tissues is repeated 24 h a day, year after year, until “death do us part”. To support this essential “pumping” process the heart must work constantly, i.e., 70–80 years (life expectancy in the U.S.). This is a remarkable feat when compared with one of our most costly people-made technologies, i.e., automobiles (cars). In the past century, it was rare to see the family car survive more than 10–15 years unless it had been subjected to motor replacement surgery. Most were laid to rest at a much earlier age. Now, in this new millennium should a brilliant car manufacturer succeed in constructing a car engine as efficient as the human heart, each family member requiring a car would need only one per life time. With this in mind, one of the major future “matters of the heart” is to keep it pumping, not only for the current 70–80 year life span but much longer. To do this depends on, among other matters, the two processes noted above, i.e., oxidative phosphorylation and glycolysis. The former is strictly a mitochondrial process that works only in the presence of oxygen whereas glycolysis, dependent on mitochondrial bound hexokinase 2 (MB-HK-2), works either in the presence or absence of oxygen. In addition, the MB-HK 2 is anti-apoptotic and helps with other factors to retard cell death. Current estimates reveal that the human heart of an individual living 70–80 years will have undergone 2.5–3.0 billion beats, a feat that is energetically feasible only due to the heart cells’ (cardiomyocytes) large population of mitochondria with bound HK-2.

Keywords

Heart Cardiomyocyte Mitochondria Oxidative phosphorylation Hexokinase-2 (HK-2) Apoptotic Anti-apoptotic 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anflous-Pharaya K, Cai ZJ, Craigen WJ (2007) Biochem. Biophys Acta 1767:136–142CrossRefGoogle Scholar
  2. Arrell DK, Elliott ST, Kane LA, Ko YH, Pedersen PL, Van Eyk JE (2006) Circ Res 99:706–714CrossRefGoogle Scholar
  3. Chen C, Ko Y, Delannoy M, Ludtke SJ, Chiu W, Pedersen PL (2004a) J Biol Chem 279:31761–31768CrossRefGoogle Scholar
  4. Chen R., Fearnley IM, Palmer DN, Walker JE (2004b) J Biol Chem 279:21883–21887Google Scholar
  5. Das A, Liungdahl LG (2003) J Bacteriol 185:5527–5535CrossRefGoogle Scholar
  6. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N (2001) Genes Dev 15:1406–1418CrossRefGoogle Scholar
  7. Hu Y, Suarez J, Fricovsky E, Fricovsky E, Wang H, Scott BT, Travuger SA, Han W, Hu Y, Oyeleyl MO, Dillmann WH (2008) J Biol Chem 284:547–555CrossRefGoogle Scholar
  8. Joshi S, Sanadi RR (1979) Meth Enzymol 55:384–391CrossRefGoogle Scholar
  9. Ko YH, Delannoy M, Hullihen J, Chiu W, Pedersen PL (2003) J Biol Chem 278:12305–12309CrossRefGoogle Scholar
  10. Lee JK, Belogrudov GI, Stroud RM (2008) Proc Natl Acad Sci (U.S. A) 105:13379–13384CrossRefGoogle Scholar
  11. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O’Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y (2009) Circulation 119:e21–e181CrossRefGoogle Scholar
  12. Mitchell P, Moyle J (1967) Nature 213:137–139CrossRefGoogle Scholar
  13. Nakashima RA, Mangan PS, Colombini M, Pedersen PL (1986) Biochemistry 25:1015–1021CrossRefGoogle Scholar
  14. Pastorino JG, Shulga N, Hoek JB (2002) J Biol Chem 277:7610–7618CrossRefGoogle Scholar
  15. Pedersen PL (1976) J Biol Chem 251:934–940Google Scholar
  16. Pedersen PL, Hullihen J (1984) J Biol Chem 259:15148–15153Google Scholar
  17. Pullman ME, Monroy GC (1963) J Biol Chem 238:3762–3769Google Scholar
  18. Sawicki G, Jugdutt BI (2007) Proteomics 12:2100–2110CrossRefGoogle Scholar
  19. Towsend DM, Findlay VJ, Frazilev F, Ogle M, Fraser J, Saavedra JE, Ji X, Keefer LK, Tew KD (2006) Mol Pharmacol 69:501–508CrossRefGoogle Scholar
  20. Vonk J, Schafer E (2009) Biochim Biophys Acta 1793:117–124CrossRefGoogle Scholar
  21. Yamada EW, Huzel NJ (1985) Cell Calcium 6:469–479CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of Biological Chemistry, School of MedicineJohns Hopkins UniversityBaltimoreUSA

Personalised recommendations